Boehringer Ingelheim

Lobbying Client  
Donor Gift Giver
May 2025 - Apr 2026 May 2024 - Apr 2025 May 2023 - Apr 2024 May 2022 - Apr 2023 May 2021 - Apr 2022 May 2020 - Apr 2021 May 2019 - Apr 2020 May 2018 - Apr 2019 May 2017 - Apr 2018 May 2016 - Apr 2017 May 2015 - Apr 2016 May 2014 - Apr 2015 May 2013 - Apr 2014 May 2012 - Apr 2013 May 2011 - Apr 2012 May 2010 - Apr 2011 May 2009 - Apr 2010 May 2008 - Apr 2009 May 2007 - Apr 2008 May 2005 - Apr 2006

Lobbyists Retained

  • Andrus, Joel
    Firm: Kemper Consulting Inc
    (Details)

    112 Granby St
    STE 400
    Norfolk, VA 23510

    757-627-1988

    Registered: 5/22/2023
    Firm: Kemper Consulting Inc
    Matters: All matters of concern to Boehringer Ingelheim Pharmaceuticals, Inc.
  • Radcliff, Marianne M
    Firm: Kemper Consulting Inc
    (Details)

    12 S 3rd St
    Richmond, VA 23219

    804-649-7945

    Registered: 5/25/2023
    Firm: Kemper Consulting Inc
    Matters: All matters of concern to Boehringer Ingelheim Pharmaceuticals, Inc.

No Longer Representing

(Show Lobbyists)
  • Filler, Nate
    (Details)

    5521 Dumfries Ct E
    Dublin, OH 43017

    614-330-6704

    Registered: 5/1/2023   Termination Date: 2/16/2024
    Matters: All matters related to healthcare and pharmaceuticals.
    Job title: Associate Director


2024 Regular Session; 2024 Special Session I
All Issues Commissions and Boards Health Insurance Prescription Medicine

HB570

2 Close Floor Votes

Prescription Drug Affordability Board; established, drug cost affordability review, report.
Chief Patron: Karrie Delaney
Status: Vetoed

SB119

Close Floor Vote

Drug manufacturers; permitting and registration, certain conditions related to 340B-covered drugs.
Chief Patron: Louise Lucas
Status: Vetoed

SB122

Pharmaceutical Services, Office of; establishes in Department of General Services, report.
Chief Patron: Schuyler VanValkenburg
Status: Killed

SB186

Wholesale prescription drug importation program; Sec. of Health and Human Resources to establish.
Chief Patron: Suhas Subramanyam
Status: Enacted

SB274

3 Close Floor Votes

Prescription Drug Affordability Board; established, drug cost affordability review, report.
Chief Patron: Creigh Deeds
Status: Vetoed

Entertainment Expenses $0
Gift Expenses $0
Communication Expenses $0
Personal Expenses $238
Employed
Nate Filler
$933
Retained
Kemper Consulting Inc
$9,838
Honoraria Expenses $0
2/15/2024: Office expenses
$125
Total Expenses $11,135
Matters: All matters related to healthcare and pharmaceuticals.

Principal contact for Boehringer Ingelheim:

  • Stacie Phan
    900 Ridgebury Rd
    Ridgefield, CT 06877

    203-778-7917

Information on this page comes from public documents on file with the office of the Virginia Conflict of Interest and Ethics Advisory Council.